Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, Bio-Rad Partner to Develop Single-Cell Genomics Workflow

NEW YORK (GenomeWeb) – Bio-Rad Laboratories and Illumina announced today an exclusive partnership to develop a comprehensive single-cell analysis workflow. Terms of the deal were not disclosed, but the companies anticipate a late 2016 or early 2017 launch.

The end-to-end commercial solution will enable high-throughput sequencing of thousands of individual cells, the companies said in a statement. The firms will combine Bio-Rad's droplet partitioning technology with Illumina's next-generation sequencing to isolate and barcode single cells, analyzing resulting data with Illumina's BaseSpace cloud infrastructure.

The scalable solution will isolate a larger number of single cells than current commercially available solutions in a few minutes and at a cost-effective price, according to the statement.

"We welcome the opportunity to collaborate with Illumina, the global leader in NGS technologies, to develop this long-awaited platform for single-cell genomics," Bio-Rad's Executive Vice President and General Manager of its Digital Biology Center, Annette Tumolo, said in a statement.

The collaboration enables both companies to serve "the significant market for single-cell NGS, enabling scientists to make groundbreaking advances in gene expression and beyond," noted Illumina Executive Vice President and Chief Commercial Officer Christian Henry. "Bio-Rad is recognized for delivering trusted, high-quality products in a market with increasingly stringent regulations and standards," he added.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.